DeepHealth

DeepHealth, a subsidiary of RadNet, builds AI-powered radiology and imaging software, including the cloud-native DeepHealth OS and FDA-cleared screening tools, deployed at 300+ sites globally.

DeepHealth develops AI-powered health informatics and medical imaging software, with products covering the radiology workflow from disease detection and assessment through monitoring and treatment planning. The company is a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT). Its technical work spans artificial intelligence and machine learning, computer vision for radiology, cloud-native platforms, health informatics, and the integration of clinical and operational data for workflow automation.

Its flagship product, DeepHealth OS, is a cloud-native operating system intended to unify data across clinical and operational workflows and to personalise AI-powered workspaces for participants in the radiology ecosystem. Around it sits an Enterprise Imaging category, comprising a Diagnostic Suite and an Operations Suite for diagnostic and operational radiology workflows respectively, together with TechLive. A separate Population Health line provides specialised imaging suites for breast, prostate, chest and thyroid, and neuro imaging.

Scale is substantial. DeepHealth reports deployment at more than 300 sites globally and says its breast imaging suite supports more than 10m mammograms annually. Its FDA-cleared AI applications include breast imaging tools for which landmark studies published in Nature Health reported a 21% increase in breast cancer detection rates. The company operates internationally and serves radiology practices, diagnostic imaging providers, population health screening programmes and enterprise health systems.

DeepHealth frames its mission around improving both clinical accuracy and operational efficiency in imaging, and describes its aim as empowering breakthroughs in care through imaging.